This document discusses antinuclear antibodies (ANAs), which are autoantibodies that bind to contents of the cell nucleus. There are many subtypes of ANAs that bind to different nuclear proteins. Indirect immunofluorescence is the reference method for detecting ANAs using three tissues and viewing under fluorescence microscopy, where positive samples show apple-green fluorescence in distinctive patterns associated with particular antigens and diseases. ANA testing is important for diagnosing and managing autoimmune conditions but can also be present in normal individuals so results need accurate interpretation.
There are very few tests which are simple to carry out, done in almost all centers, use full to narrow down the list of provisional diagnosis and also useful for predicting future outcomes. C-RP is one of them. this presentation is not only for laboratory personal but also for MBBS students. Dental students, clinical department post graduates as well as clinicians.
There are very few tests which are simple to carry out, done in almost all centers, use full to narrow down the list of provisional diagnosis and also useful for predicting future outcomes. C-RP is one of them. this presentation is not only for laboratory personal but also for MBBS students. Dental students, clinical department post graduates as well as clinicians.
I have listed out the LE cells structure and Microscopical examinaton of LE CELLS, Difference between tart cells and le cells, clinical symptoms and diagnostic procedure.
Autoimmune hemolytic anemia (or autoimmune haemolytic anaemia; AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to insufficient plasma concentration.
This presentation is focused on diagnostic utility of Red blood cell indices which will be very useful for undergraduate and postgraduate of medical field.
I have listed out the LE cells structure and Microscopical examinaton of LE CELLS, Difference between tart cells and le cells, clinical symptoms and diagnostic procedure.
Autoimmune hemolytic anemia (or autoimmune haemolytic anaemia; AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to insufficient plasma concentration.
This presentation is focused on diagnostic utility of Red blood cell indices which will be very useful for undergraduate and postgraduate of medical field.
Immunoassay basic concepts for clinical pathologistDr. Rajesh Bendre
Immunoassays as technique have evolved considerably since the invention of Radioimmunoassay, monoclonal antibody, Recombinant technology & successfully achieved automation. However, many of the hormonal assays still lack standardization and/or Harmonization resulting in significant variability in test results. Using alternate methods, adopting procedures for sample pre-treatment, serial dilution of sample are some of the ways to troubleshoot these discrepant result
serological techniques for detection of plant virus.pptxReddykumarAv
Serological tests involve diagnostic procedures for identifying antibodies and antigens in a patient's blood sample. Serology definition tells that Serological tests could be used to diagnose infections and autoimmune disorders, as well as to see whether a person is resistant to these kinds of diseases and for a variety of other purposes, including assessing a person's blood type.
For many years scientists yearned for the possibility of performing flow cytometry to analyse small bio-nanoparticles that are too small to be measured by conventional and high sensitivity instruments. These entities, extracellular vesicles, gene therapy vectors, viruses and drug delivery particles, are promised to become the next generation of therapeutics, but they have been hard to handle and characterise due to their small size and biological or chemical heterogeneity. There is therefore a strong case for bringing flow cytometry capability to the sub-200nm scale.
NanoFCM has developed the NanoAnalyzer platform that now enables true flow-cytometry measurement at the sub-micron scale, and down to particle sizes unreachable by any other flow cytometers (10-40nm depending on the nature of the substrate). Nano-flow cytometry, the technology that underpins the NanoAnalyzer, removes bias and uncertainty stemming from the use of fluorescence signal triggering by using its highly sensitive side-scatter channel to trigger particle events. The single-particle nature of the measurement prevents uncontrolled swarming events, reinforcing data integrity. High resolution of both scatter and fluorescence channels allows the assessment of subpopulations, based on size or on bio-chemical properties.
Nano-flow cytometry’s ability to measure simultaneously a (bio)-nanoparticle population for size, size distribution and bio-chemical properties on a single instrument dramatically improves data quality and throughput compared to the traditional, multiple-techniques approach involving particle characterisation and counting (DLS, NTA, RPS), combined with chemical and biological function assessment (ELISA, Western Blot, Flow Cytometry, PCR). Quantitative measurement of the active and contaminant particles in a single preparation opens up the possibility of characterisation-based nanomedicine regulatory approval, and allows the conduct of large-scale clinical studies. From the research laboratory to the quality control department, NanoFCM delivers comprehensive bio-nano analysis.
Enzyme-Linked ImmunoSorbent Assay, or ELISA, is a biochemical technique used mainly in immunology to detect the presence of an antibody or an antigen in a sample. The ELISA has been used as a diagnostic tool in medicine and plant pathology, as well as a quality control check in various industries. In simple terms, in ELISA an unknown amount of antigen is affixed to a surface, and then a specific antibody is washed over the surface so that it can bind the antigen. This antibody is linked to an enzyme, and in the final step a substance is added that the enzyme can convert to some detectable signal.
2. ANTINUCLEAR ANTIBODY
Anti-nuclear antibodies (ANAs, also known as
anti-nuclear factor or ANF) are autoantibodies
that bind to contents of the cell nucleus. In
normal individuals, the immune system produces
antibodies to foreign proteins (antigens) but not
to human proteins (autoantigens). In some
individuals, antibodies to human antigens are
produced
3. Subtypes Of ANAs
There are many subtypes of ANAs such as,
anti-Ro antibodies
anti-La antibodies
anti-Sm antibodies
anti-nRNP antibodies
anti-Scl-70 antibodies
anti-dsDNA antibodies
anti-histone antibodies
antibodies to nuclear pore complexes
anti-centromere antibodies
anti-sp100 antibodies
4. Subtypes Of ANAs
Each of these antibody subtypes binds to
different proteins or protein complexes
within the nucleus. They are found in many
disorders including autoimmunity, cancer
and infection, with different prevalence of
antibodies depending on the condition.
5. Nuclear Proteins
Proteins that have been
Synthesized in the nucleus
And thereafter where
Distributed to their
respective sites in the cell
6. Detection Technique
Indirect immunofluorescence is the reference
method for screening and titration of
circulating autoantibodies in human serum.
Using three different tissues from
rat(liver,kidney and stomach) enables
autontibodies to be more easily identifying by
comparing the results obtained with each tissue.
7. Types of ANAs
There are Three major antibodies
detected
Antinuclear antibodies (ANA)
Antimitochondrial antibodies (AMA)
Antismooth muscle antibodies
(ASMA)
8. Principle
An indirect immunofluorescence technique is
utilized where patient samples and appropriate
controls are incubated with the substrate slides.
The unreacted antibodies are washed off and an
appropriate fluorescence labeled conjugate is
applied.
Unbound conjugate is washed off, and slides are
viewed with a fluorescence microscope.
Positive samples produce apple-green
fluorescence.
11. Importance Of ANA
Serologic hallmarks of patients with
systemic autoimmune disease (ANA
diseases).
Can provide further diagnostic and
prognostic data concerning patients who
have minimal symptoms or who have
clinical features of more than one
autoimmune disease.
12. Limitations of ANA
Their presence does not mandate the presence of
illness, since they can also be found in otherwise
normal individuals.
Accurate interpretation of different nuclear
patterns is confounded several difficulties as:
One nuclear pattern may obscure and prevent
the recognition of another pattern if several
antibodies are present simultaneously.